Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126709791 | 12670979 | 1 | I | 20160808 | 20160822 | 20160822 | EXP | DE-MLMSERVICE-20160801-0362725-1 | DE-ACCORD-043267 | ACCORD | ZSCHABITZ S, LASITSCHKA F, JAGER D, GRULLICH C. ACTIVITY OF IMMUNE CHECKPOINT INHIBITION IN PLATINUM REFRACTORY GERM-CELL TUMORS. ANNALS OF ONCOLOGY. 2016; ARTICLE NUMBER MDW146 : 27(7):1356-1360 | 0.00 | Y | 0.00000 | 20160822 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126709791 | 12670979 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | 74513 | ||||||||||||
| 126709791 | 12670979 | 2 | SS | GEMCITABINE/GEMCITABINE HYDROCHLORIDE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | U | 91594 | |||||||||||
| 126709791 | 12670979 | 3 | SS | PACLITAXEL/PACLITAXEL LIPOSOME | PACLITAXEL | 1 | U | 75436 | |||||||||||
| 126709791 | 12670979 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | U | 200750112 | |||||||||||
| 126709791 | 12670979 | 5 | SS | THIOTEPA. | THIOTEPA | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126709791 | 12670979 | 1 | Extragonadal primary germ cell tumour |
| 126709791 | 12670979 | 2 | Extragonadal primary germ cell tumour |
| 126709791 | 12670979 | 3 | Extragonadal primary germ cell tumour |
| 126709791 | 12670979 | 4 | Extragonadal primary germ cell tumour |
| 126709791 | 12670979 | 5 | Extragonadal primary germ cell tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126709791 | 12670979 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126709791 | 12670979 | Drug ineffective | |
| 126709791 | 12670979 | Haematotoxicity | |
| 126709791 | 12670979 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |